Grow your business safely with ASCOPHARM RESSOURCES

All the information you need about ASCOPHARM RESSOURCES to develop and secure your business in France

A HOME > CORPORATES > ASCOPHARM RESSOURCES > BALANCE SHEET ( 2020-08-19)

THE LIST OF BALANCE SHEET : ASCOPHARM RESSOURCES

CORPORATEBOBACCESTABLISHMENTSMANAGERSFINANCE
Deposit Confidentiality closing date document
2022-08-16 Public 2021-12-31 Complete
2021-08-20 Public 2020-12-31 Complete
2020-08-19 Public 2019-12-31 Complete
2019-07-04 Public 2018-12-31 Complete
2018-07-27 Public 2017-12-31 Complete
2017-07-24 Public 2016-12-31 Complete
NameASCOPHARM RESSOURCES
Siren410739668
Closing2019-12-31
Registry code 7501
Registration number 61302
Management number1997B01672
Activity code 7490B
Closing date n-12018-12-31
Duration Fiscal year 12
Duration Fiscal year n-112
Filing date2020-08-19
Modification00 Annual accounts entered without anomaly
Balance sheet typeC : Complete
Currency codeEUR
ConfidentialityPublic
Address75009 PARIS
1 - Assets (balance sheet)Gross amount year NAmortization year NNet year NNet year N-1
BX Customers and related accounts 172 800.00 172 800.00 172 800.00
BZ Other receivables 68 916.00 68 916.00 68 916.00
CF Cash and cash equivalents 158 326.00 158 326.00 158 326.00
CH Prepaid expenses
CJ TOTAL (II) 400 042.00 400 042.00 400 042.00
CO Grand total (0 to V) 400 042.00 400 042.00 400 042.00
2 - Liabilities (balance sheet)Amount year NAmount year N-1
DA Share or individual capital 7 622.00 7 622.00 7 622.00
DD Legal reserve (1) 762.00 762.00 762.00
DH Retained earnings 219 914.00 183 336.00 219 914.00
DI RESULTS FOR THE YEAR (Profit or Loss) -31 289.00 36 578.00 -31 289.00
DL TOTAL (I) 197 010.00 228 299.00 197 010.00
DV Miscellaneous Loans and Financial Debts (4) 327.00 327.00 327.00
DX Trade payables and related accounts 168 000.00 168 000.00 168 000.00
DY Tax and social security liabilities 34 705.00 29 904.00 34 705.00
EC TOTAL (IV) 203 032.00 198 231.00 203 032.00
EE Grand total (I to V) 400 042.00 426 530.00 400 042.00
EG Accrued income and payables due within one year 203 032.00 198 231.00 203 032.00
3 - Income statementAmount France year NAmount Export year NTotal year NTotal year N-1
FG Production sold - services
FJ Net sales
FQ Other income
FR Total operating income (I)
FW Other purchases and external expenses 30 832.00
FX Taxes, duties, and similar payments 457.00
FY Salaries and Wages
FZ Social Security Contributions
GE Other Expenses 6.00
GF Total Operating Expenses (II) 31 289.00
GG - OPERATING RESULT (I - II) -31 289.00
GW - CURRENT INCOME BEFORE TAX (I - II + III - IV + V - VI) -31 289.00
4 - Income statement (continued)Amount year NAmount year N-1
HK Income tax 2 091.00
HL TOTAL REVENUE (I + III + V + VII) 160 071.00
HM TOTAL EXPENSES (II + IV + VI + VIII + IX + X) 31 289.00 123 493.00 31 289.00
HN PROFIT OR LOSS (Total revenue - Total expenses) -31 289.00 36 578.00 -31 289.00
8 - Receivables and payablesGross amountAmount within 1 yearAmount 1 to 5 yearsAmount more than 5 years
8B Suppliers and Related Accounts 168 000.00 168 000.00 168 000.00
UX Other trade receivables 172 800.00 172 800.00 172 800.00
VB VAT 68 916.00 68 916.00 68 916.00
VI Group and Associates 327.00 327.00 327.00
VT TOTAL – STATEMENT OF RECEIVABLES 241 716.00 241 716.00 241 716.00
VW VAT 34 705.00 34 705.00 34 705.00
VY TOTAL – STATEMENT OF LIABILITIES 203 032.00 203 032.00 203 032.00
11 - Earnings appropriation & miscellaneous informationAmount for year NAmount for year N-1Amount 1 to 5 yearsAmount more than 5 years
9Z Other taxes, duties, and similar payments 457.00 1 466.00 457.00
SS Intermediary remuneration and fees (excluding retrocessions) 30 000.00 30 490.00 30 000.00
ST Other accounts 832.00 7 798.00 832.00
YX Total of the account corresponding to line FX of table no. 2052 457.00 1 466.00 457.00
YY Amount of VAT collected 10 011.00
YZ Total deductible VAT on goods and services 12 009.00 15 957.00 12 009.00
ZJ Total of the item corresponding to line FW of table no. 2052 30 832.00 38 288.00 30 832.00

all companies in France

Complete and comprehensive database.